Premium
COVID‐19 in the absence of eosinophils: The outcome of confirmed SARS‐CoV‐2 infection whilst on treatment with benralizumab
Author(s) -
Francis Charles H. R.,
Hearn Andrew P.,
Ratnakumar Sharenja,
Taylor Alexander,
Duckitt Jordan,
Ahmed Usmaan,
Dhariwal Jaideep,
Nanzer Alexandra M.,
Jackson David J.
Publication year - 2022
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.15334
Subject(s) - benralizumab , medicine , eosinopenia , immunology , asthma , eosinophil , virology , mepolizumab